Therapeutics News and Research

RSS

Cellular program could turn T cells into effective cancer killers

Cancer-fighting immune cells in patients with lung cancer whose tumors do not respond to immunotherapies appear to be running on a different "program" that makes them less effective than immune cells in patients whose cancers respond to these immune treatments, suggests a new study led by researchers at the Johns Hopkins Kimmel Cancer Center Bloomberg~Kimmel Institute for Cancer Immunotherapy.

9 Sep 2021

Government launches a wide-ranging consultation to change UK’s data landscape

The Information Commissioner's Office is set for an overhaul to drive greater innovation and growth in the UK's data sector and better protect the public from major data threats, under planned reforms announced by the Digital Secretary Oliver Dowden today.

9 Sep 2021

Highly extensive Gut Cell Atlas will transform research into intestinal diseases

Many diseases have their origin in early human development, and today (8th September), two publications in Nature reveal how researchers from the Human Cell Atlas (HCA) consortium are advancing understanding of this.

9 Sep 2021

Potential pancoronavirus fusion inhibitors that are effective against SARS-CoV-2 variants

A new study successfully identifies a series of inhibitors that possesses pancoronavirus activity against SARS-CoV, SARS-CoV-2, and MERS-CoV.

7 Sep 2021

Cancer immunotherapies could benefit older patients as much as younger people

A retrospective analysis of large datasets of biomarkers from tumors and healthy tissue by researchers at the Johns Hopkins Kimmel Cancer Center Convergence Institute suggests that older cancer patients could benefit as much as younger patients from cancer immunotherapies.

7 Sep 2021

Combining Big Health’s digital therapeutic for insomnia and IAPT therapy improves mental health

Big Health, a digital therapeutics company dedicated to helping millions back to good mental health, and the Oxford Health NHS Foundation Trust today announced a joint study published in the Behavior Research and Therapy journal showing almost two-thirds of people seeking treatment for anxiety or depression and who had sleep difficulty saw their mental health improve substantially more by combining enrollment in Sleepio, Big Health’s digital therapeutic for insomnia, with NHS Improving Access to Psychological Therapies programme care, when compared to IAPT care alone.

7 Sep 2021

New convection-enhanced MEDs could offer faster, more effective treatment for T1D patients

More than 40 million people worldwide are affected with type 1 diabetes (T1D) mellitus, an autoimmune disease in which insulin producing β-cells in the pancreas are destroyed by the immune system.

6 Sep 2021

New Health Declaration published with commitments from all G20 countries

G20 Health Ministers have united to pledge global action to improve future health security, increase vaccine confidence and tackle antimicrobial resistance.

6 Sep 2021

Health Secretary urges G20 countries to recognize UK's COVID-19 vaccine clinical trial participants

The rights of vaccine clinical trial volunteers must be safeguarded to help protect everyone against future health crises, Health and Social Care Secretary Sajid Javid will tell G20 health leaders in Rome today (Sunday 5 September).

5 Sep 2021

SARS-CoV-2 fusion peptides play distinct roles according to neutron scattering

A new study determines the physical and thermodynamic events associated with the interactions that lead to the fusion between SARS-CoV-2 and the host.

5 Sep 2021

Practical solutions in shoulder arthroplasty for patients with glenoid bone loss

Today, at the American Academy of Orthopaedic Surgeons (AAOS) 2021 annual meeting, Hospital for Special Surgery (HSS) sports medicine surgeon David M. Dines, MD, participated in an instructional case lecture on practical solutions in shoulder arthroplasty for patients with substantial shoulder socket bone loss known as glenoid bone deficiency.

4 Sep 2021

Weill Cornell receives NIH support to advance TB research

Tuberculosis (TB) is one of the deadliest infectious diseases in history and one of the few that naturally infects only humans.

4 Sep 2021

Antibody cocktail neutralizes SARS-CoV-2 and has projected protection up to 12 months

A new study reports long-lasting, effective protection against severe disease with the AZD7442 antibody cocktail.

3 Sep 2021

Researchers assess robotic and navigation assisted pedicle screw placement in degenerative spinal surgery

The use of robotics and computer navigation in spinal surgery is rapidly expanding. Increasing numbers of hospitals and spine surgeons are adopting the technology, which aims to enhance precision, accuracy and predictability, according to Darren R. Lebl, MD, MBA, a spine surgeon at Hospital for Special Surgery.

2 Sep 2021

Study establishes a new resource for exploring and understanding Alzheimer's disease

A study led by researchers from Brigham and Women's Hospital has established a new resource for exploring and understanding Alzheimer's disease (AD) on an individualized level.

2 Sep 2021

UTSA receives $3.2 million CPRIT grant for developing new approach to fight against cancer

The University of Texas at San Antonio has been awarded a five-year $3.2 million grant from the Cancer Prevention & Research Institute of Texas.

2 Sep 2021

Center for Health Innovation at UC San Diego Health seeks to develop patient-centered technologies

From tele-monitoring patients with diabetes to using artificial intelligence to prevent sepsis, the newly launched Center for Health Innovation at UC San Diego Health will seek to develop, test and commercialize technologies that make a real, measurable difference in the lives and wellbeing of patients.

2 Sep 2021

Study could help physicians better manage patients experiencing debilitating stiffness after revision TKA

A new study by researchers at Hospital for Special Surgery in New York City presented today at the American Academy of Orthopaedic Surgeons 2021 annual meeting could help physicians better manage patients who experience debilitating stiffness after they undergo knee replacement surgery.

2 Sep 2021

Cellular protein may be a potential new target for treating osteoporosis

A cellular protein whose normal function appears to suppress bone formation may be a potential new target for treating osteoporosis, suggests a collaborative study led by Weill Cornell Medicine and NewYork-Presbyterian investigators.

1 Sep 2021

Implanted cells deliver a biologic drug in response to inflammation in rheumatoid arthritis

With a goal of developing rheumatoid arthritis therapies with minimal side effects, researchers at Washington University School of Medicine in St. Louis have genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation.

1 Sep 2021

Therapeutics News and Research

Cellular program could turn T cells into effective cancer killers

Government launches a wide-ranging consultation to change UK’s data landscape

Highly extensive Gut Cell Atlas will transform research into intestinal diseases

Potential pancoronavirus fusion inhibitors that are effective against SARS-CoV-2 variants

Cancer immunotherapies could benefit older patients as much as younger people

Combining Big Health’s digital therapeutic for insomnia and IAPT therapy improves mental health

New convection-enhanced MEDs could offer faster, more effective treatment for T1D patients

New Health Declaration published with commitments from all G20 countries

Health Secretary urges G20 countries to recognize UK's COVID-19 vaccine clinical trial participants

SARS-CoV-2 fusion peptides play distinct roles according to neutron scattering

Practical solutions in shoulder arthroplasty for patients with glenoid bone loss

Weill Cornell receives NIH support to advance TB research

Antibody cocktail neutralizes SARS-CoV-2 and has projected protection up to 12 months

Researchers assess robotic and navigation assisted pedicle screw placement in degenerative spinal surgery

Study establishes a new resource for exploring and understanding Alzheimer's disease

UTSA receives $3.2 million CPRIT grant for developing new approach to fight against cancer

Center for Health Innovation at UC San Diego Health seeks to develop patient-centered technologies

Study could help physicians better manage patients experiencing debilitating stiffness after revision TKA

Cellular protein may be a potential new target for treating osteoporosis

Implanted cells deliver a biologic drug in response to inflammation in rheumatoid arthritis

Understanding the DNA Damage Response in Innate Immunity eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News